These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 11849411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
    Wang M, Liu S, Ouyang N, Song E, Lutz J, Heemann U.
    Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.
    Gröne HJ, Weber C, Weber KS, Gröne EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlöndorff D, Nelson PJ.
    FASEB J; 1999 Aug; 13(11):1371-83. PubMed ID: 10428761
    [Abstract] [Full Text] [Related]

  • 6. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A.
    Circulation; 2004 Feb 24; 109(7):932-7. PubMed ID: 14757698
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
    Liu M, Gu M, Wu Y, Zhu P, Zhang W, Yin C, Zhang WJ.
    J Surg Res; 2009 Nov 24; 157(1):e117-27. PubMed ID: 19589538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection.
    Hamar P, Liu S, Viklický O, Szabó A, Múller V, Heemann U.
    Transplantation; 2000 Apr 15; 69(7):1290-5. PubMed ID: 10798743
    [Abstract] [Full Text] [Related]

  • 16. Expression of the integrin-linked kinase in a rat kidney model of chronic allograft nephropathy.
    Han C, Zou H, Li Q, Wang Y, Shi Y, Lv T, Chen L, Zhou W.
    Cell Biochem Biophys; 2011 Sep 15; 61(1):73-81. PubMed ID: 21350838
    [Abstract] [Full Text] [Related]

  • 17. Opposite effects of testosterone and estrogens on chronic allograft nephropathy.
    Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U.
    Transpl Int; 2002 Oct 15; 15(9-10):494-501. PubMed ID: 12389082
    [Abstract] [Full Text] [Related]

  • 18. Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival.
    Vassalli G, Simeoni E, Li JP, Fleury S.
    Transplantation; 2006 Jan 27; 81(2):240-6. PubMed ID: 16436968
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.
    Adams J, Kiss E, Arroyo AB, Bonrouhi M, Sun Q, Li Z, Gretz N, Schnitger A, Zouboulis CC, Wiesel M, Wagner J, Nelson PJ, Gröne HJ.
    Am J Pathol; 2005 Jul 27; 167(1):285-98. PubMed ID: 15972972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.